Jade Malette

Increase funds for diabetes in the Federal Budget specifically to increase funds directed to the Framework for Diabetes in Canada its components and a strategy to reflect growth in diabetes prevalence and cost. Bill C-64 - An Act Respecting Pharmacare Increase Federal funding for Diabetes Research - work directed towards increasing funding to federal granting councils, in particular CIHR through the Federal Budget. Aboriginal Diabetes Initiative - work towards making funding for this Initiative permanent. (Previous work directed towards continuation of funding beyond 2010).

Issues with respect to the implementation of Bill C-64, An Act respecting pharmacare Work with the Government of Canada to bolster and create pan-Canadian standardized health data and digital tools to better track and have an up-to-date picture of diabetes and it's evolving impacts. Increase funds for diabetes in the Federal Budget specifically to increase funds directed to the Canadian Diabetes Strategy to reflect growth in diabetes prevalence and cost. Increase Federal funding for Diabetes Research - work directed towards increasing funding to federal granting councils, in particular the Canadian Institutes of Health Research (CIHR) through the Federal Budget. Funding for Implementation of the Framework for Diabetes tabled by the Minister of Health on October 5, 2022.

Engaging government with respect to the importance of the Canada/US/Mexico Free Trade Agreement (CUSMA) to the life sciences sector & ensuring open supply chains to trade partners and tariff-free access to medical devices. Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems. Working with Food, Health & Consumer Products (FHCP) Infant Formula Council on the proposed regulatory modernization of Food & Drug Regulations Divisions 24 & 25.

Hazardous Products Act and Regulations regarding interpretation and technical amendments/guidance to the Workplace Hazardous Materials Information System

Health and security policies and programs relating to the domestic distribution of products and the integrity of the supply chain. Drug pricing and pharmacare with regard to the pharmaceutical wholesale distribution chain.

Inform the Government of Canada of the experience that Ontario hospitals are having with the timelines to expand Medical Assistance in Dying Doubling the funding investment to the Tri-Council (CIHR, NSERC, and SSHRC) to bring Canada into competitive balance globally. Advocate for increased funding into Canada Health Transfers to help bolster healthcare delivery capacity. Advocate for federal action on the Health Human Resources (HHR) crisis by delivering a Pan-Canadian strategy that addresses recruitment, retention, and other key issues.

promote innovations in medical technologies (equipment, services and digital solutions) that support better care for more people across Canada. This includes mobile and virtual solutions which can improve access to care in rural and remote regions of the country, while reducing costs and environmental impacts.